JP2022545416A5 - - Google Patents
Info
- Publication number
- JP2022545416A5 JP2022545416A5 JP2022510804A JP2022510804A JP2022545416A5 JP 2022545416 A5 JP2022545416 A5 JP 2022545416A5 JP 2022510804 A JP2022510804 A JP 2022510804A JP 2022510804 A JP2022510804 A JP 2022510804A JP 2022545416 A5 JP2022545416 A5 JP 2022545416A5
- Authority
- JP
- Japan
- Prior art keywords
- cells
- tcrαβ
- population
- precursor
- icos
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1911958.5A GB201911958D0 (en) | 2019-08-20 | 2019-08-20 | Methods of t cell production |
| GB1911958.5 | 2019-08-20 | ||
| PCT/EP2020/073332 WO2021032836A1 (en) | 2019-08-20 | 2020-08-20 | Methods of t cell production |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022545416A JP2022545416A (ja) | 2022-10-27 |
| JP2022545416A5 true JP2022545416A5 (https=) | 2023-08-18 |
Family
ID=68099410
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022510804A Pending JP2022545416A (ja) | 2019-08-20 | 2020-08-20 | Ｔ細胞の生産方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20220267729A1 (https=) |
| EP (1) | EP4017966A1 (https=) |
| JP (1) | JP2022545416A (https=) |
| KR (1) | KR20220047376A (https=) |
| CN (1) | CN114364790A (https=) |
| AU (1) | AU2020332059A1 (https=) |
| CA (1) | CA3150425A1 (https=) |
| GB (1) | GB201911958D0 (https=) |
| WO (1) | WO2021032836A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20240240149A1 (en) * | 2021-05-18 | 2024-07-18 | The University Of British Columbia | A method for producing blood progenitor and progenitor t cells, resulting cells and methods and uses thereof |
| GB202205572D0 (en) | 2022-04-14 | 2022-06-01 | Adaptimmune Ltd | Engineered T cells |
| GB202208545D0 (en) | 2022-06-10 | 2022-07-27 | Adaptimmune Ltd | Production of immune cells |
| EP4599054A1 (en) * | 2022-10-05 | 2025-08-13 | Garuda Therapeutics, Inc. | Pluripotent stem cell-derived t cell populations and progenitors thereof |
| GB202318950D0 (en) | 2023-12-12 | 2024-01-24 | Adaptimmune Ltd | Production of immune cells |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7575925B2 (en) * | 2002-12-10 | 2009-08-18 | Sunnybrook Health Sciences Centre | Cell preparations comprising cells of the T cell lineage and methods of making and using them |
| ES2724451T3 (es) * | 2010-02-04 | 2019-09-11 | Univ Pennsylvania | ICOS regula fundamentalmente la expansión y la función de linfocitos Th17 humanos inflamatorios |
| SG11201803419PA (en) * | 2015-10-30 | 2018-05-30 | The Regents Of The Universtiy Of California | Methods of generating t-cells from stem cells and immunotherapeutic methods using the t-cells |
| GB201616238D0 (en) * | 2016-09-23 | 2016-11-09 | Adaptimmune Ltd | Modified T cells |
| CN110199017A (zh) * | 2017-01-20 | 2019-09-03 | 国立大学法人京都大学 | CD8α+β+细胞毒性T细胞的制备方法 |
| KR20230166145A (ko) * | 2017-03-15 | 2023-12-06 | 옥스포드 바이오메디카(유케이) 리미티드 | 방법 |
| WO2018176144A1 (en) * | 2017-03-29 | 2018-10-04 | Sunnybrook Research Institute | Engineered t-cell modulating molecules and methods of using same |
| JP2020528885A (ja) * | 2017-07-19 | 2020-10-01 | フェイト セラピューティクス，インコーポレイテッド | 養子免疫療法における免疫細胞調節のための組成物および方法 |
| GB202102297D0 (en) * | 2021-02-18 | 2021-04-07 | Adaptimmune Ltd | Methods of Producing Haemogenic Endothelial Cells from Pluripotent Stem Cells |
-
2019
- 2019-08-20 GB GBGB1911958.5A patent/GB201911958D0/en not_active Ceased
-
2020
- 2020-08-20 US US17/630,884 patent/US20220267729A1/en not_active Abandoned
- 2020-08-20 AU AU2020332059A patent/AU2020332059A1/en not_active Abandoned
- 2020-08-20 JP JP2022510804A patent/JP2022545416A/ja active Pending
- 2020-08-20 KR KR1020227009208A patent/KR20220047376A/ko active Pending
- 2020-08-20 WO PCT/EP2020/073332 patent/WO2021032836A1/en not_active Ceased
- 2020-08-20 CN CN202080059142.9A patent/CN114364790A/zh active Pending
- 2020-08-20 EP EP20761182.3A patent/EP4017966A1/en not_active Withdrawn
- 2020-08-20 CA CA3150425A patent/CA3150425A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022545416A5 (https=) | ||
| JP7560502B2 (ja) | 多能性幹細胞からｈｌａホモ接合免疫細胞への指向分化方法 | |
| US12129486B2 (en) | Methods for directed differentiation of pluripotent stem cells to immune cells | |
| JP2019083819A (ja) | ヒト胚性幹細胞由来血管芽細胞からナチュラルキラー細胞および樹状細胞を生成する方法 | |
| JP2022545782A5 (https=) | ||
| JP7522800B2 (ja) | 造血移植片の改善方法 | |
| JP2022545415A5 (https=) | ||
| JP2020506713A (ja) | 多能性幹細胞から模倣自然免疫細胞を生成する方法及びキット | |
| US20230210904A1 (en) | Pharmaceutical containing helper t cells induced from pluripotent stem cells | |
| JP2022545078A5 (https=) | ||
| US20150087065A1 (en) | Method for generation of conditionally immortalized hematopoietic progenitor cell lines with multiple lineage potential | |
| JP2023164892A (ja) | 造血前駆細胞マーカー | |
| CA3024273A1 (en) | Selection of human hematopoetic stem cells using epcr | |
| CN115698270A (zh) | 一种通过iPS细胞生产再生T细胞的方法 | |
| EP4101924A1 (en) | Cytotoxic t cells derived from human t cell-derived ips cells | |
| Kawai et al. | Feeder-free generation of CD4 single-positive helper T cells from human iPSCs via stage-specific modulation of Notch and TCR Signaling | |
| AU2019376495B2 (en) | Method for producing erythroid cells | |
| CN117480249A (zh) | 包含未重排的t细胞受体(tcr)基因座的干细胞及其使用方法 | |
| Botó | ZBTB46 and RUNX3 Regulated Blood Cell Differentiation from Pluripotent Embryonic Stem Cells | |
| WO2026011501A1 (zh) | 一种靶向cd19的car-nk细胞及其制备方法和应用 | |
| JP2025534356A (ja) | 細胞療法のためのｃｄ７１＋赤血球前駆細胞の拡張可能な拡大培養 | |
| JPWO2021085450A1 (ja) | マウスｍａｉｔ様細胞及びｍａｉｔ細胞豊富なマウス | |
| Crooks | Common lymphoid progenitors |